Cardinal Health, Inc. $CAH Shares Sold by Triad Wealth Partners LLC

Triad Wealth Partners LLC cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,553 shares of the company’s stock after selling 118 shares during the period. Triad Wealth Partners LLC’s holdings in Cardinal Health were worth $261,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI boosted its position in Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Cardinal Health during the first quarter valued at about $106,065,000. Finally, T. Rowe Price Investment Management Inc. purchased a new stake in shares of Cardinal Health during the first quarter worth about $104,951,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

CAH has been the subject of a number of analyst reports. Evercore ISI reduced their price target on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Bank of America increased their target price on Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a research note on Tuesday, June 10th. Citigroup restated a “neutral” rating and issued a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research note on Saturday, September 27th. Finally, Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $165.93.

Cardinal Health Price Performance

Shares of CAH opened at $154.50 on Friday. The stock has a market capitalization of $36.71 billion, a PE ratio of 23.95, a price-to-earnings-growth ratio of 1.34 and a beta of 0.71. The business’s fifty day moving average price is $152.07 and its 200 day moving average price is $150.25. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the prior year, the company earned $1.84 earnings per share. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s payout ratio is presently 31.63%.

Insider Activity at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the sale, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by insiders.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.